The company's customer wins this year suggest more revenue expansion to come. In fact, C3.ai forecasts fiscal 2026 sales to ...

A buck converter is a DC-DC power device that efficiently steps down a voltage to a lower level. It uses an inductor, ...

This has led to strong growth for the company, with C3.ai's revenue rising 25% year over year in fourth-quarter fiscal year 2025 (ending April 30). It also expects strong growth for FY 2026, with ...

Upgrade your portfolio! C3.ai is a strong buy with explosive growth, top-tier partnerships, and AI exposure at a discount.

McLaren did not waste any time in stamping its authority on the Hungarian Grand Prix weekend. Lando Norris and Oscar Piastri, ...

I've been writing about the LG C3 OLED TV since its release in 2023, and it has consistently been a best-seller, thanks to ...

Four astronauts are on their way to the International Space Station after being sidelined by Boeing's Starliner trouble and ...

Investing.com -- Teleperformance (EPA: TEPRF) shares plunged more than 16% on Friday after the company cut its full-year revenue outlook, reported weaker-than-expected margins and missed earnings ...

Huntington Ingalls Industries Inc (HII) reports a 3.5% revenue increase and significant contract awards, while navigating ...

Alpha Dhabi’s sustained focus on capturing strategic opportunities and continued momentum in executing its strategy across key verticals is evident in the strong financial performance, with group ...

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized ...

Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the biotech stocks to buy according to Wall Street analysts.